BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26803514)

  • 1. Iron chelator-induced apoptosis via the ER stress pathway in gastric cancer cells.
    Kim JL; Lee DH; Na YJ; Kim BR; Jeong YA; Lee SI; Kang S; Joung SY; Lee SY; Oh SC; Min BW
    Tumour Biol; 2016 Jul; 37(7):9709-19. PubMed ID: 26803514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of iron depletion in palmitate-induced lipotoxicity of beta cells.
    Jung IR; Choi SE; Jung JG; Lee SA; Han SJ; Kim HJ; Kim DJ; Lee KW; Kang Y
    Mol Cell Endocrinol; 2015 May; 407():74-84. PubMed ID: 25779532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of deferasirox as a novel therapeutic modality in gastric cancer.
    Choi JH; Kim JS; Won YW; Uhm J; Park BB; Lee YY
    World J Surg Oncol; 2016 Mar; 14():77. PubMed ID: 26965928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelators induce autophagic cell death in multiple myeloma cells.
    Pullarkat V; Meng Z; Donohue C; Yamamoto VN; Tomassetti S; Bhatia R; Krishnan A; Forman SJ; Synold TW
    Leuk Res; 2014 Aug; 38(8):988-96. PubMed ID: 24998390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress.
    Kim JL; Lee DH; Jeong S; Kim BR; Na YJ; Park SH; Jo MJ; Jeong YA; Oh SC
    Oncol Rep; 2019 Mar; 41(3):1616-1626. PubMed ID: 30569109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells.
    Antosiewicz J; Herman-Antosiewicz A; Marynowski SW; Singh SV
    Cancer Res; 2006 May; 66(10):5379-86. PubMed ID: 16707465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer.
    Zou P; Zhang J; Xia Y; Kanchana K; Guo G; Chen W; Huang Y; Wang Z; Yang S; Liang G
    Oncotarget; 2015 Mar; 6(8):5860-76. PubMed ID: 25714022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective killing of gastric cancer cells by a small molecule targeting ROS-mediated ER stress activation.
    Zou P; Xia Y; Chen T; Zhang J; Wang Z; Chen W; Chen M; Kanchana K; Yang S; Liang G
    Mol Carcinog; 2016 Jun; 55(6):1073-86. PubMed ID: 26086416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator.
    Salehi S; Saljooghi ASh; Shiri A
    Eur J Pharmacol; 2016 Jun; 781():209-17. PubMed ID: 27090924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.
    Harima H; Kaino S; Takami T; Shinoda S; Matsumoto T; Fujisawa K; Yamamoto N; Yamasaki T; Sakaida I
    BMC Cancer; 2016 Aug; 16(1):702. PubMed ID: 27582255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrochalcone Echinatin Triggers Apoptosis of Esophageal Squamous Cell Carcinoma via ROS- and ER Stress-Mediated Signaling Pathways.
    Kwak AW; Choi JS; Lee MH; Oh HN; Cho SS; Yoon G; Liu K; Chae JI; Shim JH
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31717502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Pyrazine-PPD, a novel dammarane derivative, showed anticancer activity by reactive oxygen species-mediate apoptosis and endoplasmic reticulum stress in gastric cancer cells.
    De Wang X; Li T; Li Y; Yuan WH; Zhao YQ
    Eur J Pharmacol; 2020 Aug; 881():173211. PubMed ID: 32464194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells.
    Kim DS; Na YJ; Kang MH; Yoon SY; Choi CW
    Korean J Intern Med; 2016 Mar; 31(2):357-66. PubMed ID: 26874514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway.
    Xue Y; Zhang G; Zhou S; Wang S; Lv H; Zhou L; Shang P
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
    Lee DH; Jang PS; Chung NG; Cho B; Jeong DC; Kim HK
    Exp Hematol; 2013 Jun; 41(6):539-46. PubMed ID: 23415674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.
    Ford SJ; Obeidy P; Lovejoy DB; Bedford M; Nichols L; Chadwick C; Tucker O; Lui GY; Kalinowski DS; Jansson PJ; Iqbal TH; Alderson D; Richardson DR; Tselepis C
    Br J Pharmacol; 2013 Mar; 168(6):1316-28. PubMed ID: 23126308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.
    Zhu Y; Jiang Y; Shi L; Du L; Xu X; Wang E; Sun Y; Guo X; Zou B; Wang H; Wang C; Sun L; Zhen Y
    Biomed Pharmacother; 2017 Mar; 87():527-538. PubMed ID: 28076833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E platinum, a newly synthesized platinum compound, induces apoptosis through ROS-triggered ER stress in gastric carcinoma cells.
    Wang X; Guo Q; Tao L; Zhao L; Chen Y; An T; Chen Z; Fu R
    Mol Carcinog; 2017 Jan; 56(1):218-231. PubMed ID: 27061377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models.
    Kim HS; Lim JM; Kim JY; Kim Y; Park S; Sohn J
    Int J Cancer; 2016 Mar; 138(6):1432-41. PubMed ID: 26421996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
    Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
    Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.